X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (64) 64
humans (63) 63
index medicus (57) 57
middle aged (56) 56
chemotherapy (53) 53
female (53) 53
male (53) 53
aged (52) 52
cancer (45) 45
adult (40) 40
antineoplastic combined chemotherapy protocols - therapeutic use (36) 36
gastric cancer (36) 36
stomach cancer (34) 34
medicine & public health (31) 31
metastasis (31) 31
cancer research (29) 29
stomach neoplasms - drug therapy (28) 28
surgical oncology (27) 27
treatment outcome (27) 27
care and treatment (26) 26
cisplatin (24) 24
patients (24) 24
analysis (22) 22
gastroenterology (22) 22
oxaliplatin (22) 22
survival rate (22) 22
trial (22) 22
gastroenterology & hepatology (21) 21
stomach neoplasms - pathology (21) 21
survival (21) 21
abdominal surgery (20) 20
antineoplastic combined chemotherapy protocols - adverse effects (18) 18
cancer therapies (18) 18
cisplatin - administration & dosage (18) 18
retrospective studies (18) 18
antimitotic agents (17) 17
antineoplastic agents (17) 17
colorectal cancer (17) 17
fluorouracil - administration & dosage (17) 17
fluorouracil (16) 16
metastases (16) 16
research (16) 16
disease-free survival (15) 15
drug combinations (15) 15
s-1 (15) 15
therapy (15) 15
aged, 80 and over (14) 14
clinical trials (14) 14
esophageal cancer (14) 14
follow-up studies (14) 14
neoplasm staging (14) 14
prognosis (14) 14
cancer patients (13) 13
combination (13) 13
oncology, experimental (13) 13
original (13) 13
adenocarcinoma (12) 12
colorectal neoplasms - drug therapy (12) 12
medical research (12) 12
paclitaxel (12) 12
stomach neoplasms - mortality (12) 12
5-fluorouracil (11) 11
camptothecin - administration & dosage (11) 11
camptothecin - analogs & derivatives (11) 11
irinotecan (11) 11
original article (11) 11
phase-iii (11) 11
surgery (11) 11
tegafur - administration & dosage (11) 11
tumors (11) 11
gastrectomy (10) 10
medical prognosis (10) 10
oxonic acid - administration & dosage (10) 10
adjuvant chemotherapy (9) 9
adjuvant treatment (9) 9
bevacizumab (9) 9
esophagus (9) 9
leucovorin (9) 9
studies (9) 9
toxicity (9) 9
adenocarcinoma - drug therapy (8) 8
antineoplastic agents - therapeutic use (8) 8
carcinoma (8) 8
cetuximab (8) 8
colorectal neoplasms - pathology (8) 8
esophageal neoplasms - drug therapy (8) 8
esophageal neoplasms - pathology (8) 8
mutation (8) 8
neoplasm recurrence, local - drug therapy (8) 8
open-label (8) 8
organoplatinum compounds - administration & dosage (8) 8
squamous-cell carcinoma (8) 8
chemotherapy, adjuvant (7) 7
colorectal carcinoma (7) 7
disease progression (7) 7
drug therapy (7) 7
fluorouracil - adverse effects (7) 7
kaplan-meier estimate (7) 7
liver neoplasms - secondary (7) 7
multicenter (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Gastric Cancer, ISSN 1436-3291, 3/2011, Volume 14, Issue 1, pp. 72 - 80
Irinotecan hydrochloride and S-1, an oral fluoropyrimidine, have shown antitumor activity against advanced gastric cancer as single agents in phase I/II... 
Pathology | Phase III | Irinotecan S-1 | Medicine & Public Health | Gastroenterology | Oncology | Radiotherapy | Surgical Oncology | Gastric cancer | Randomized controlled trial | CPT-11 | ADENOCARCINOMA | FOLINIC ACID | COMBINATION | FLUOROURACIL | DOCETAXEL | CHEMOTHERAPY | TRIAL | 5-FLUOROURACIL | CISPLATIN | ONCOLOGY | GASTROENTEROLOGY & HEPATOLOGY | Follow-Up Studies | Humans | Middle Aged | Male | Antimetabolites, Antineoplastic - administration & dosage | Young Adult | Antineoplastic Agents, Phytogenic - administration & dosage | Adult | Camptothecin - administration & dosage | Female | Antineoplastic Agents, Phytogenic - therapeutic use | Antineoplastic Agents, Phytogenic - adverse effects | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Camptothecin - therapeutic use | Tegafur - adverse effects | Tegafur - therapeutic use | Neoplasm Recurrence, Local | Antineoplastic Combined Chemotherapy Protocols | Treatment Outcome | Oxonic Acid - administration & dosage | Stomach Neoplasms - drug therapy | Disease Progression | Oxonic Acid - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Oxonic Acid - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Tegafur - administration & dosage | Aged | Drug Combinations | Medical colleges | Care and treatment | Oncology, Experimental | Diarrhea | Research | Drug therapy | Stomach cancer | Cancer | Original
Journal Article
Investigational New Drugs, ISSN 0167-6997, 8/2012, Volume 30, Issue 4, pp. 1621 - 1627
Journal Article
Cancer Science, ISSN 1347-9032, 09/2014, Volume 105, Issue 9, pp. 1189 - 1195
Journal Article
Journal Article
by Shitara, Kohei and Özgüroğlu, Mustafa and Bang, Yung-Jue and Di Bartolomeo, Maria and Mandalà, Mario and Ryu, Min-Hee and Fornaro, Lorenzo and Olesiński, Tomasz and Caglevic, Christian and Chung, Hyun C and Chung, Hyun Cheol and Muro, Kei and Goekkurt, Eray and Mansoor, Wasat and McDermott, Raymond S and Shacham-Shmueli, Einat and Chen, Xinqun and Chen, Jen-Shi and Mayo, Carlos and Kang, S Peter and Ohtsu, Atsushi and Fuchs, Charles S and Lerzo, Guillermo and O'Connor, Juan Manuel and Mendez, Guillermo Ariel and Lynam, James and Tebbutt, Niall and Wong, Mark and Strickland, Andrew and Karapetis, Chris and Goldstein, David and Vasey, Paul and Van Laethem, Jean-Luc and Van Cutsem, Eric and Berry, Scott and Vincent, Mark and Muller, Bettina and Rey, Felipe and Zambrano, Angela and Guerra, Joaquin and Krogh, Merete and Baeksgaard, Lene and Yilmaz, Mette and Elme, Anneli and Magi, Andrus and Auvinen, Paivi and Alanko, Tuomo and Moehler, Markus and Kunzmann, Volker and Seufferlein, Thomas and Thuss-Patience, Peter and Hoehler, Thomas and Haag, Georg and Al-Batran, Salah-Eddin and Castro, Hugo and Lopez, Karla and Aguilar Vasquez, Mynor and Sandoval, Mario and Lam, Ka On and Cuffe, Sinead and Kelly, Cathy and Geva, Ravit and Hubert, Ayala and Beny, Alex and Brenner, Baruch and Giuseppe, Aprile and Falcone, Alfredo and Maiello, Evaristo and Passalacqua, Rodolfo and Montesarchio, Vincenzo and Hara, Hiroki and Chin, Keisho and Nishina, Tomohiro and Komatsu, Yoshito and Machida, Nozumo and Hironaka, Shuichi and Satoh, Taroh and Tamura, Takao and Sugimoto, Naotaoshi and Cho, Haruhiko and Omuro, Yashushi and Kato, Ken and Goto, Masahiro and Hyodo, Ichinosuke and Yoshida, Kazuhiro and Baba, Hideo and Esaki, Taito and Furuse, Junji and Wan Mohammed, Wan Zamaniah and Hernandez Hernandez, Carlos and Casas Garcia, Juan and Dominguez Andrade, Adriana and Clarke, Katriona and Hjortland, Geir and Glenjen, Nils and Kubiatowski, Tomasz and Jacek, Jassem and Wojtukiewicz, Marek and Lazarev, Sergey and Lancukhay, Yuri and ... and KEYNOTE-061 Investigators and KEYNOTE-061 investigators
The Lancet, ISSN 0140-6736, 07/2018, Volume 392, Issue 10142, pp. 123 - 133
Journal Article
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1637 - 1651
Journal Article
Gastric Cancer, ISSN 1436-3291, 3/2017, Volume 20, Issue 2, pp. 332 - 340
Journal Article
Journal Article
Cancer Science, ISSN 1347-9032, 10/2018, Volume 109, Issue 10, pp. 3253 - 3262
Journal Article